Загрузка...
Efficacy and safety of rituximab in autoimmune and microangiopathic hemolytic anemia: a systematic review and meta-analysis
BACKGROUND: The efficacy and safety of rituximab (RTX) on hemolytic anemia (HA) is unknown. Therefore we retrospectively analyze the efficacy and safety of RTX in autoimmune hemolytic anemia (AIHA) and microangiopathic hemolytic anemia (MAHA) from the previous literature. METHODS: Data in clinical t...
Сохранить в:
| Опубликовано в: : | Exp Hematol Oncol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7161265/ https://ncbi.nlm.nih.gov/pubmed/32322437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-020-00163-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|